It is estimated to reach $1.93 billion by 2029, growing at a compound annual growth ... Several leading businesses in the targeted alpha-therapy market are concentrating their efforts on creating ...

Early research suggests a brain test may predict whether antidepressants will cause sexual dysfunction. There has never been ...

Immatics is advancing Anzu-cel, a T-cell receptor therapy for melanoma with potential for significant annual revenue. Learn ...

This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

Eli Lilly and Company (NYSE: LLY) today announced that new data from across its oncology portfolio and pipeline will be ...

Lilly to present new clinical data for Verzenio and multiple novel pipeline programMEs at the 2025 ESMO annual meeting: Indianapolis Tuesday, October 14, 2025, 09:00 Hrs [IST] Eli ...

Novo Nordisk is well-positioned in the obesity drug market, with strong financials and anticipation for its oral Wegovy pill.

A new study has found that the hormone estrogen plays a protective role against stress-induced, depression-like behaviors in ...

FDA grants orphan drug designation to cintredekin besudotox, offering new hope for glioblastoma treatment with targeted ...

Sanofi reports that its AlphaMedix phase 2 trial showed strong efficacy and survival benefits in gastroenteropancreatic ...

Background： Sepsis is a complex clinical syndrome characterized by dysregulated immune responses, systemic inflammation, and ...